Menu Back toSession 3: Data Sources

Future of Evidence and Smart Health Conference

Leveraging RWE to advance healthcare decision-making.


Session 3: Data Sources

Session Chair(s)

Michael  Lees, MA

Michael Lees, MA

  • Chief Operating Officer and Head of Market Access Strategy
  • PHMR Ltd, United Kingdom
As the importance of real world evidence to healthcare decision makers continues to grow, so do the questions addressed by real world evidence and the sources of such evidence. In addition to the various sources of claims data and data from health records in North America, EU and Asia, the number of registries developed to shed further light on disease management, outcomes and real world effectiveness continues to grow, while data captured from less traditional sources such as early access programs and social media is also increasingly used. This session aims to identify the emerging trends when making the choice about the most appropriate choices for the sources of real world evidence from the perspective of HTA bodies, real world evidence practitioners and pharmaceutical industry.

Speaker(s)

Cormac  Sammon, PhD

Insights from a RWE Practitioner

Cormac Sammon, PhD

  • Chief Epidemiologist and Head of RWE
  • PHMR, United Kingdom
Antonia  Panayi

The Industry (Medical Affairs) Perspective

Antonia Panayi

  • Global Medical Research Head Excellence
  • Takeda, Switzerland
Amr  Makady, PharmD, PhD, MSc

The Access Perspective

Amr Makady, PharmD, PhD, MSc

  • Health Economics and Market Access Manager
  • Johnson & Johnson, Netherlands
Michael  Lees, MA

Panel Discussion with Q&A, Moderated by:

Michael Lees, MA

  • Chief Operating Officer and Head of Market Access Strategy
  • PHMR Ltd, United Kingdom

Contact us

Trouble connecting on the day of the event?

Send Email
+41 61 225 51 51


Registration Questions?

Send Email
+41 61 225 51 51